UFPT UFP Technologies

UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum

UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum

NEWBURYPORT, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum to be held virtually on March 19 and 20, 2024. UFP’s presentation is scheduled to begin at 9:45 AM ET on Wednesday, March 20, 2024.

About UFP Technologies, Inc.

UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsourcing partner to many of the top medical device manufacturers in the world. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.

Contacts:

Ron Lataille, CFO, UFP Technologies, Inc., tel. 978-234-0926

  

Jeff Elliott, Three Part Advisors, LLC, tel. 214-966-9014



EN
19/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on UFP Technologies

 PRESS RELEASE

UFP Technologies Announces Record Q1 Results

UFP Technologies Announces Record Q1 Results NEWBURYPORT, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $12.7 million or $1.64 per diluted common share outstanding for its first quarter ended March 31, 2024, compared to net income of $9.7 million or $1.27 per diluted common share outstanding for the first quarter of 2023. Net Sales for the first quarter were $105.0 million compared to 2023 first quarter sales of $97.8 million. “I am...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyB...

UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum NEWBURYPORT, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum ...

UFP Technologies Inc: 3 directors

Three Directors at UFP Technologies Inc sold after exercising options/sold 30,814 shares at between 207.768USD and 209.475USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades ...

 PRESS RELEASE

UFP Technologies Announces Record 2023 Results

UFP Technologies Announces Record 2023 Results NEWBURYPORT, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $44.9 million or $5.83 per diluted common share outstanding for its year ended December 31, 2023, compared to net income of $41.8 million or $5.45 per diluted common share outstanding for 2022. Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million. For its fourth quarter ended December 31, 2023, th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch